Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Eva Hvizdala"'
Autor:
Robert E. Kalina, Lynn C. Moscinski, Kevin S. Buckley, Avery H. Weiss, Eva Hvizdala, Thomas W. Pendergrass
Publikováno v:
Journal of Pediatric Hematology/Oncology. 18:130-134
Purpose : Patients with metastatic retinoblastoma have a poor outcome. Hope that early detection of extraocular spread will improve survival has led to routine monitoring with bone marrow and cerebrospinal fluid (CSF) examinations. In light of cost a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447d7c95fc5180021e3d1580bfcedee8
https://doi.org/10.1097/00043426-199605000-00006
https://doi.org/10.1097/00043426-199605000-00006
Autor:
Eva Hvizdala, Martin L. Brecher, Jonathan J. Shuster, Jeanette Pullen, Costan W. Berard, Teresa J. Vietti, William M. Crist, Abdel Ragab, Irma Ramirez, Margaret P. Sullivan
Publikováno v:
Journal of Pediatric Hematology/Oncology. 13:288-295
The Pediatric Oncology Group (POG) investigated a high-dose cyclophosphamide (CPM) high-dose methotrexate (MTX) regimen to determine therapeutic efficacy in confirmed advanced nonlymphoblastic non-Hodgkin's lymphoma (NHL) (stages III and IV) and B-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac1fd24fe043f650becef1bd27dd754
https://doi.org/10.1097/00043426-199123000-00007
https://doi.org/10.1097/00043426-199123000-00007
Publikováno v:
The Journal of Urology. :1987-1989
The prevalence of enuresis and management options for this condition were studied in our population of sickle cell patients. A total of 91 active patients (6 to 21 years old) followed at our regional sickle cell center was surveyed for the symptoms o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4034e67e2b9dd12c0ab728f92a24c21d
https://doi.org/10.1097/00005392-199506000-00087
https://doi.org/10.1097/00005392-199506000-00087
Publikováno v:
Journal of pediatric hematology/oncology. 24(9)
This report describes the sustained response of an Iranian girl with homozygous beta(0) thalassemia (IVS-II-1G-->A) to hydroxyurea (HU) and recombinant erythropoietin (rEPO). Since the start of this regimen 7 years ago, she has been transfusion-indep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6166d379596b53c19fc788b656694bd
https://pubmed.ncbi.nlm.nih.gov/12468925
https://pubmed.ncbi.nlm.nih.gov/12468925
Publikováno v:
British Journal of Haematology. 89:947-948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c4c18846f7c2df989c40b26a302532
https://doi.org/10.1111/j.1365-2141.1995.tb08449.x
https://doi.org/10.1111/j.1365-2141.1995.tb08449.x
Autor:
John M. Falletta, Jonathan J. Shuster, Costan W. Berard, H Sabio, Moody D. Wharam, Eva Hvizdala, Margaret P. Sullivan, Thomas R. Callihan
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 9(7)
From May 1979 to March 1983, 93 eligible patients with nonlymphoblastic lymphoma (NLBL) were treated by members of the Pediatric Oncology Group (POG) with Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), vincristine, prednisone, cyclophosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3ea871cc2f274cfd2fa30e1850a3e7
https://pubmed.ncbi.nlm.nih.gov/2045859
https://pubmed.ncbi.nlm.nih.gov/2045859
Autor:
John M. Falletta, Sharon B. Murphy, J A Katz, Jonathan J. Shuster, Molly Schwenn, Eva Hvizdala
Publikováno v:
Journal of Clinical Oncology. 11:2054-2055
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e7c94ada64940b30ec09df602f99949
https://doi.org/10.1200/jco.1993.11.10.2054
https://doi.org/10.1200/jco.1993.11.10.2054
Autor:
C. Philip Steuber, Vita J. Land, Robert P. Castleberry, Paul J. Thomas, Eva Hvizdala, Abdelsalam H. Ragab, Samuel K. Morgan, Teresa J. Vietti, Steven J. Culbert, Jeffrey P. Krischer, D. H. Berry
Publikováno v:
Medical and Pediatric Oncology. 17:401-408
Complete remission (CR), 5-year remission duration (RD), and overall 5-year survival rates are 74%, 28% and 25%, respectively, for previously untreated children with acute nonlymphocytic leukemia diagnosed between 1977 and 1981, following induction t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1569f1ea87e2ebd46a83e4194075f7af
https://doi.org/10.1002/mpo.2950170509
https://doi.org/10.1002/mpo.2950170509
Autor:
Margaret P. Sullivan, Eva Hvizdala, Bharat N. Nathwani, Rogers C. Griffith, Costan W. Berard, Jonathan J. Shuster, Sharon B. Murphy, David R. Kelly
Publikováno v:
Cancer. 59:1138-1142
Of 227 cases of pediatric non-Hodgkin's lymphoma with adequate histopathologic material for review, 72 (32%) were classified as diffuse "histiocytic" lymphoma (DHL). These cases were further divided into different morphologic subtypes according to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5755b2a9aba04da2eda465d69d5baa63
https://doi.org/10.1002/1097-0142(19870315)59:6<1138::aid-cncr2820590617>3.0.co
https://doi.org/10.1002/1097-0142(19870315)59:6<1138::aid-cncr2820590617>3.0.co
Autor:
David R. Kelly, Rogers C. Griffith, Margaret P. Sullivan, Eva Hvizdala, Jonathan J. Shuster, Costan W. Berard, Bharat N. Nathwani, Sharon B. Murphy
Publikováno v:
Cancer. 59:1126-1131
For this study 227 non-Hodgkin's lymphomas, registered through the Pediatric Oncology Group clinical studies between 1976 and 1982, were morphologically subclassified into major histologic types and subtypes, and their histopathologic and clinical fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6010981a9a12ad7534746ec534a508ae
https://doi.org/10.1002/1097-0142(19870315)59:6<1126::aid-cncr2820590615>3.0.co
https://doi.org/10.1002/1097-0142(19870315)59:6<1126::aid-cncr2820590615>3.0.co